[Treatment of renal insufficiency in patients with multiple myeloma]. 1996

D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
Institute of Kidney Diseases and Metabolic Disorders, Zvezdara Clinical Hospital Centre, Belgrade.

Multiple myeloma is the most frequent dysproteinaemica causing renal damage. Renal damage can be manifested as acute or chronic renal failure, Tubular disfunction, urinary tract infection, or as proteinuria. The aim of this study is to present our experience in the treatment of renal failure developed during multiple myeloma. Over a ten year period we treated 16 uraemic patients with multiple myeloma and renal failure. Most patients (75% or 12 of them) came to the nephrologic department because of acute renal failure provoked by multiple myeloma. Dialysis was applied to 9 patients. The average survival rate of these patients ranged from 6.2 +/- 9.2 months, while three patients lived for 23-24 months. The combination of chemotherapy and dialysis did not produce recovery of renal function in any case of acute renal failure. All deaths were related to the evolution of multiple myeloma and none to a complication of dialysis. In conclusion, dialysis treatment should be used even in cases of uraemia, if myeloma is not in the terminal phase.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D051437 Renal Insufficiency Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. Kidney Insufficiency,Kidney Failure,Renal Failure,Failure, Kidney,Failure, Renal,Failures, Kidney,Failures, Renal,Insufficiency, Kidney,Kidney Failures,Kidney Insufficiencies,Renal Failures,Renal Insufficiencies

Related Publications

D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
July 1994, Ugeskrift for laeger,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
November 1982, Archives of internal medicine,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
January 1969, Acta clinica Belgica,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
March 1983, Schweizerische medizinische Wochenschrift,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
April 1977, Journal of the National Cancer Institute,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
February 2021, Leukemia & lymphoma,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
January 1964, Acta clinica Belgica,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
January 1978, Medicina,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
October 2016, Zhonghua nei ke za zhi,
D Vulić, and O Radlović, and A Stanojcić, and A Radmilović, and M Rajić
January 2013, Clinical advances in hematology & oncology : H&O,
Copied contents to your clipboard!